🇺🇸 FDA
Pipeline program

ISIS 721744

ISIS 721744-CS7

Phase 3 small_molecule active

Quick answer

ISIS 721744 for Hereditary Angioedema is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Hereditary Angioedema
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials